CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-02 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Sale | −400 | $139.25 | $56K | 963 |
| 2020-11-02 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −10,504 | 653,496 | ||
| 2020-04-30 | Paladin Capital Management, LLC 10% owner | Sale | −1,000,000 | $78.25 | $78.3M | 5,617,583 |
| 2020-04-21 | Paladin Capital Management, LLC 10% owner | Sale | −568 | $74.48 | $42K | 6,617,583 |
| 2020-03-17 | Paladin Capital Management, LLC 10% owner | Other disposition | −1,527,241 | 6,618,151 | ||
| 2020-03-16 | Paladin Capital Management, LLC 10% owner | Other disposition | −619,306 | 8,055,861 | ||
| 2020-02-20 | Paladin Capital Management, LLC 10% owner | Conversion | +8,675,167 | 8,675,167 | ||
| 2020-02-20 | Paladin Capital Management, LLC 10% owner | Conversion · Class B Common Stock | −8,675,167 | 0 |
Page 57 of 57 · 1,128 trades